Budget Range
Min
€1,500
Average
€45,026
Max
€229,826
Role Distribution
Sector Distribution
Budget by Sector (€)
Projects (31)
P
Precision drug REPurpOsing For EUrope and the world
Health101057619
€229,826
P
bridGing gaps in caRdiAC health managEment
Health101194778
€117,363
P
SoluTions foR mItiGatinG climate-induced hEalth tReaths
Health101057739
€99,968
P
Reducing the impact of major environmental challenges on mental health
Health101057429
€90,453
C
Enabling the WHO-Roadmap 2030
Health101103053
€79,671
P
Receptor-Focused Interventions Against Orthoflavivirus Neuroinvasion and Entry
Health101191791
€77,053
P
Biomarkers established to stratify sepsis long-term adverse effects to improve patients’ health and quality of life
Health101137484
€69,129
P
ARTIFICIAL INTELLIGENCE BASED HEALTH, OPTIMISM, PURPOSE, AND ENDURANCE IN PALLIATIVE CARE FOR DEMENTIA
Health101136769
€64,190
P
Trustworthy AI Tools for the Prediction of Obesity Related Vascular Diseases
Health101080302
€52,928
P
REPURPOSING FUSIDIC ACID AS A SHORT-COURSE ONCHOCERCA VOLVULUS MACROFILARICIDE: A RANDOMIZED CONTROLLED OPEN-LABEL PARALLEL GROUP INTERVENTION PHASE IIA/B PILOT TRIAL
Health101190778
€51,217
P
CANCER PREVENTION VS CANCER TREATMENT: THE RARE TUMOUR RISK SYNDROMES BATTLE
Health101095483
€46,422
P
PALliative Care Yields Cancer welLbEing Support
Health101057243
€44,740
P
BRaIn Disease monitoring throuGh the lifE span powered by Artificial Intelligence
MSCA (Marie Skłodowska-Curie)101225642
€36,269
P
OutMARCH-ing cancer: Towards innovative membrane protein degrader modalities for cancer treatment
HORIZON.3.1101259018
€29,991
P
REPRESSIT: A novel class of clinical immune checkpoint inhibitors
HORIZON.3.1101098965
€28,965
P
FuEl ThE bRaiN In healtThY aging and agE-relateD diseases
MSCA (Marie Skłodowska-Curie)101072759
€26,293
P
Tools4Teams: Research Training to Design and Implement Tools Supporting Safe Teamwork in Healthcare
MSCA (Marie Skłodowska-Curie)101072843
€25,692
C
A Foundation Model for Next-Generation Generalizable AI in Neuro-Radiology
ERC (European Research Council)101171462
€25,334
C
Re-Defining early Parkinson’s disease
ERC (European Research Council)101169580
€24,637
C
Exploring inflammasome activation and targeted inhibition
ERC (European Research Council)101098206
€21,550
P
A data-driven computational framework to discover how behavior impacts processing in mouse visual cortex
ERC (European Research Council)101171526
€19,996
C
Endogenous Retroelements As Transcriptional Parasites And Modulators Of Host Immunity
HORIZON.1.1101045497
€19,994
C
Negative Regulation of Inflammatory Responses Revealed with Camelid Nanobodies
HORIZON.1.1101125593
€19,978
C
Inflammatory signals of cell death
ERC (European Research Council)101044133
€19,913
C
Temporally complex odour information encoding
HORIZON.1.1101077017
€15,000
P
STRENGTHENING UKRAINE’S RESEARCH EXCELLENCE IN THE FIELD OF ANTIMICROBIAL RESISTANCE UNDER A ONE HEALTH APPROACH
Widening Participation101160053
€14,999
C
Turning off the furnace: the intracellular brake systems for brown fat thermogenesis
ERC (European Research Council)101078516
€14,995
C
Targeting epilepsy with phototherapeutics
HORIZON.1.1101039945
€14,994
P
Development of a multimodal toolbox to ensure a fast and reliable diagnosis of consciousness disorders
MSCA (Marie Skłodowska-Curie)101131344
€10,994
C
Exposing the glial metabolism - common link to brain damage
MSCA (Marie Skłodowska-Curie)101068962
€1,738
C
Nanobodies to prevent hematopoietic stem cell bias and hyper-inflammation.
ERC (European Research Council)101123144
€1,500